Eli Lilly acute migraine drug succeeds in late-stage study Ruby Khatun Khatun7 Aug 2017 9:18 AM ISTDrugmaker Eli Lilly and Co said on Friday its acute migraine drug lasmiditan succeeded in a key late-stage study, setting the stage for U.S....
Pharma stocks under pressure, fall up to 5 percent Ruby Khatun Khatun7 Aug 2017 9:16 AM ISTNew Delhi: Pharma stocks were under selling pressure, falling up to 5 per cent, led by Biocon and Dr Reddy's Lab.Shares of Morepen Laboratories fell...
Regeneron beats profit view, to end antibody deal with Sanofi Ruby Khatun Khatun7 Aug 2017 9:15 AM ISTRegeneron Pharmaceuticals Inc reported a much better-than-expected quarterly profit on strong demand for its flagship Eylea drug and said it would end...
Why No investigation against Roche for anti-competitive practices, questions HC Ruby Khatun Khatun6 Aug 2017 11:00 AM ISTNew Delhi: Can truth in vilification of a competitor be a defence against allegation of anti-competitive conduct. This was the poser by Delhi High...
European Patent Office to Grant Merck's Patent Application for CRISPR Technology Ruby Khatun Khatun6 Aug 2017 9:30 AM ISTDARMSTADT, Germany: Merck, a leading science and technology company, announced the European Patent Office (EPO) has issued a "Notice of Intention to...
Punjab to examine feasibility of new drug for Hepatitis-C Ruby Khatun Khatun6 Aug 2017 9:30 AM ISTChandigarh: Punjab Chief Minister Captain Amarinder Singh asked the health department to examine the feasibility of a new drug Epclusa for treatment...
Big Pharma plans to turn rural India into a cash cow Ruby Khatun Khatun6 Aug 2017 9:20 AM ISTBy Ari AltstedterFirst, foreign food brands flooded India with chips, cookies and soft drinks that fundamentally changed the nation’s eating habits....
Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration Ruby Khatun Khatun6 Aug 2017 9:16 AM ISTNew York & Boulder, Colo.: Bristol-Myers Squibb Company and Clovis Oncology, Inc. announced the companies have entered into a clinical...
USFDA to review Teva and Celltrion's cancer biosimilar drug Ruby Khatun Khatun6 Aug 2017 9:15 AM ISTJERUSALEM: Teva Pharmaceutical Industries and South Korea's Celltrion said the U.S. Food and Drug Administration has accepted for review a biologics...
Pharma Bro Shkreli convicted of US securities fraud Ruby Khatun Khatun6 Aug 2017 9:14 AM ISTNew York: A US jury convicted former hedge fund manager and pharmaceutical executive Martin Shkreli, once dubbed "The Most Hated Man in America," of...
Average trade margin on knee implants as high as 313 percent: NPPA Ruby Khatun Khatun5 Aug 2017 12:30 PM ISTNew Delhi: Drug price regulator NPPA said it has found average trade margin on orthopaedic knee implants to be as high as 313 per cent and has invited...
Narayana Hrudayalaya Q1 net profit slips 36% to Rs 11 crore Ruby Khatun Khatun5 Aug 2017 9:30 AM ISTMumbai: Narayana Hrudayalaya Ltd reported a 36 per cent decline in net profit at Rs 10.9 crore in the first quarter ended June 30 from Rs 17.2 crore...
